Skip to main content
. 2005 Feb 10;7(2):64–69. doi: 10.1186/bcr1007

Table 1.

Impact of adjuvant chemotherapy on reducing annual odds of recurrence and death

Comparison (n) Recurrence Death
CMF versus nil (8150) +24 ± 3 +14 ± 4
CMF+ versus nil (3218) +20 ± 5 +15 ± 5
Anthracyclines+ versus CMF (6950) +12 ± 4 +11 ± 5
Longer versus shorter (6104) +7 ± 4 -1 ± 5

Values are expressed as percentage ± standard deviation. Data from Early Breast Cancer Trialists' Collaborative Group [3]. CMF, cyclophosphamide, methotrexate and 5-fluorouracil.